We are live on
!
Find out more
PCM
Prelude Capital Management Portfolio holdings
AUM
$1.31B
1-Year Est. Return
62.02%
This Fund
S&P 500
This Quarter
Est. Return
+9.77%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$1.54B
AUM Growth
-$135M
(-8.1%)
Cap. Flow
-$214M
Cap. Flow
% of AUM
-13.95%
Top 10 Holdings %
Top 10 Hldgs %
25.05%
Holding
1,512
New
379
Increased
290
Reduced
289
Closed
425
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
+$10.9M |
| 2 |
ARNC
Arconic Corporation
ARNC
|
+$7.33M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$7.14M |
| 4 |
NetEase
NTES
|
+$7.01M |
| 5 |
Micron Technology
MU
|
+$6.95M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$65.4M |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$62.2M |
| 3 |
Li Auto
LI
|
+$29.4M |
| 4 |
CVII
Churchill Capital Corp VII Class A Common Stock
CVII
|
+$15.1M |
| 5 |
Alibaba
BABA
|
+$10.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.1% |
| 2 | Consumer Discretionary | 11.71% |
| 3 | Healthcare | 9.05% |
| 4 | Industrials | 8.79% |
| 5 | Financials | 6.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
876
Acco Brands
ACCO
$407M
| $154K | 0.01% |
29,500
-1,800
| -6% | -$9.05K |
|
877
CoreCivic
CXW
$3.19B
| $152K | 0.01% |
+16,131
| New | +$146K |
|
878
Hain Celestial
HAIN
$53.7M
| $151K | 0.01% |
12,106
-1,157
| -9% | -$17K |
|
879
Acumen Pharmaceuticals
ABOS
$176M
| $150K | 0.01% |
+31,100
| New | +$149K |
|
880
Designer Brands
DBI
$333M
| $149K | 0.01% |
+14,771
| New | +$122K |
|
881
Aurinia Pharmaceuticals
AUPH
$2.11B
| $149K | 0.01% |
15,395
-227
| -1% | -$2.36K |
|
882
Cricut
CRCT
$1.22B
| $146K | 0.01% |
+11,964
| New | +$131K |
|
883
Frontier Group Holdings
ULCC
$1.7B
| $145K | 0.01% |
15,006
-6,303
| -30% | -$56.6K |
|
884
Titan International
TWI
$475M
| $144K | 0.01% |
12,578
-13,693
| -52% | -$145K |
|
|
TE
885
T1 Energy
TE
$1.63B
| $144K | 0.01% |
15,407
-5,222
| -25% | -$39.2K |
|
886
GoodRx Holdings
GDRX
$1.26B
| $144K | 0.01% |
26,061
+11,705
| +82% | +$63K |
|
887
Xperi
XPER
$348M
| $143K | 0.01% |
+10,877
| New | +$118K |
|
|
DAWN
888
DELISTED
Day One Biopharmaceuticals
DAWN
| $142K | 0.01% |
+11,900
| New | +$155K |
|
889
Clarus
CLAR
$143M
| $142K | 0.01% |
+15,536
| New | +$137K |
|
890
Sutro Biopharma
STRO
$421M
| $140K | 0.01% |
3,017
-62
| -2% | -$3.09K |
|
891
Achieve Life Sciences
ACHV
$683M
| $140K | 0.01% |
26,992
+11,772
| +77% | +$82.6K |
|
892
uniQure
QURE
$3.22B
| $138K | 0.01% |
+12,009
| New | +$228K |
|
893
Vital Farms
VITL
$525M
| $137K | 0.01% |
+11,429
| New | +$160K |
|
894
Inogen
INGN
$164M
| $136K | 0.01% |
+11,817
| New | +$139K |
|
895
Upland Software
UPLD
$15.4M
| $136K | 0.01% |
3,790
+1,078
| +40% | +$37.1K |
|
896
Arhaus
ARHS
$1.36B
| $134K | 0.01% |
12,826
+255
| +2% | +$2.08K |
|
|
GLOP
897
DELISTED
GASLOG PARTNERS LP
GLOP
| $132K | 0.01% |
+15,325
| New | +$131K |
|
898
OmniAb
OABI
$447M
| $132K | 0.01% |
26,183
-11,911
| -31% | -$48.3K |
|
|
MRC
899
DELISTED
MRC Global
MRC
| $131K | 0.01% |
13,054
-362
| -3% | -$3.42K |
|
900
Cardio Diagnostics
CDIO
$5.3M
| $131K | 0.01% |
+3,667
| New | +$207K |
|
Similar funds
PFBT
CCP
SP
HCS
SPC
GPCM
MCM
CC
Prelude Capital Management's Q2 2023 Portfolio in Review
As of Q2 2023, Prelude Capital Management held 1,512 positions worth $1.54B, down 8.1% from $1.67B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Prelude Capital Management withdrew a net $214M in Q2 2023, closing 425 positions and reducing 289 holdings. Its most notable exit was Li Auto, an estimated $29.4M position sold in full.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 14% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Prelude Capital Management opened a new position in Arconic Corporation worth $7.86M.
- Prelude Capital Management's largest Q2 2023 buy was Arconic Corporation: 265,725 shares worth $7.86M.
- Prelude Capital Management added most to IVERIC bio, Inc. Common Stock in Q2 2023, an estimated $10.9M increase.
- Prelude Capital Management's biggest Q2 2023 reduction was iShares Russell 2000 ETF, cutting an estimated $65.4M.
- Prelude Capital Management fully exited Li Auto in Q2 2023, selling an estimated $29.4M.
- Prelude Capital Management's ten largest holdings make up 25% of its $1.54B portfolio in Q2 2023.
- Prelude Capital Management opened 379 new positions and closed 425 in Q2 2023.
- Prelude Capital Management's portfolio value fell 8.1% quarter-over-quarter to $1.54B.
Based on Prelude Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.